Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $31.9600 (-1.21%) ($31.9600 - $31.9600) on Thu. Jan. 27, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.7% (three month average) | RSI | 18 | Latest Price | $31.9600(-1.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1% a day on average for past five trading days. | Weekly Trend | HALO declines -4.8% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(53%) IWO(48%) IWM(47%) IWN(44%) IWC(43%) | Factors Impacting HALO price | HALO will decline at least -1.35% in a week (0% probabilities). VIXM(-27%) UUP(-13%) VXX(-9%) TBT(-3%) GLD(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.35% (StdDev 2.7%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $20.03(-37.33%) | Resistance Level | $35.99 | 5 Day Moving Average | $33.34(-4.14%) | 10 Day Moving Average | $33.87(-5.64%) | 20 Day Moving Average | $35.99(-11.2%) | To recent high | -22.1% | To recent low | 0.5% | Market Cap | $4.368b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |